Pregnancy Clinical Trial
Official title:
Using the Healthcare Visit to Improve Contraceptive Use
Consistent and correct use of an effective contraceptive method is a primary determinant in
preventing pregnancy. Unfortunately, only a minority of healthcare providers adequately
address women’s contraceptive needs. We have developed a standardized behavioral-based
contraceptive counseling model that can be used by providers and other clinic staff to
address this limitation. The model, ESP, is an adaptation of motivational interviewing and
involves: Exploring discrepancies between pregnancy intention and contraceptive use and
between risk of STDs and condom use; Sharing information; and Promoting behaviors to reduce
risk.
Study question: Does ESP counseling lead to an increase in consistency and effectiveness of
contraceptive use among women at risk of unintended pregnancy?
Methods: Randomized controlled trial of 747 women, ages 16-44, at self-identified risk of
unintended pregnancy enrolled from March 2003 to September 2004 at healthcare settings in
North Carolina. Intervention participants received individualized ESP counseling from a
health educator to address barriers to effective and consistent contraceptive use. Risk
reduction steps were negotiated. Pregnancy, Chlamydia infection and contraceptive use were
assessed at baseline and follow-up. “Highly effective” contraceptive use was defined as a
combination of effectiveness and consistency. Women in the control arm received general
preventive health counseling (e.g., smoking and exercise). Differences between the study
arms at 12-months may illustrate the longer term influence of the intervention.
Status | Completed |
Enrollment | 747 |
Est. completion date | September 2005 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 16 Years to 44 Years |
Eligibility |
Inclusion Criteria: - Women aged 16-44 - English-speaking - Do not wish to be pregnant or unsure of pregnancy intention - Have an appointment for non-acute care - Currently using no method of contraception, inconsistent use of methods, pills, condoms, diaphragms, periodic abstinence, or methods associated with higher pregnancy rates - Ability to read at least at 8th grade level - Willing to participate in follow-up visits at 2, 8, and 12 months - Able to be contacted by telephone Exclusion Criteria: - Women less than 16 or greater than 44 years - Women who are sterilized, or whose partners are sterilized or who use the IUD for contraception - Appointments for acute care - Non-English speaking - Inability to read at or above 8th grade level - Pregnant at time of enrollment - Lack of ability for telephone contact |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Educational/Counseling/Training
Country | Name | City | State |
---|---|---|---|
United States | Center for Women's Health Research, Universoty of North Carolina | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Centers for Disease Control and Prevention | University of North Carolina |
United States,
Petersen R, Payne P, Albright J, Holland H, Cabral R, Curtis KM. Applying motivational interviewing to contraceptive counseling: ESP for clinicians. Contraception. 2004 Mar;69(3):213-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Contraceptive use | |||
Primary | Chlamydia infection | |||
Primary | Pregnancy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02528136 -
The Clinical Carbetocin Myocardium Trial
|
Phase 4 |